• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝裂原活化蛋白激酶14/p38α塑造子宫内膜癌的分子格局并促进致瘤特性。

MAPK14/p38α shapes the molecular landscape of endometrial cancer and promotes tumorigenic characteristics.

作者信息

Joseph Sayali, Zhang Xingyuan, Droby Gaith N, Wu Di, Bae-Jump Victoria, Lyons Scott, Mordant Angie, Mills Allie, Herring Laura, Rushing Blake, Bowser Jessica L, Vaziri Cyrus

机构信息

Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.

出版信息

Cell Rep. 2025 Jan 28;44(1):115104. doi: 10.1016/j.celrep.2024.115104. Epub 2024 Dec 20.

DOI:10.1016/j.celrep.2024.115104
PMID:39708320
Abstract

The molecular underpinnings of high-grade endometrial carcinoma (HGEC) metastatic growth and survival are poorly understood. Here, we show that ascites-derived and primary tumor HGEC cell lines in 3D spheroid culture faithfully recapitulate key features of malignant peritoneal effusion and exhibit fundamentally distinct transcriptomic, proteomic, and metabolomic landscapes compared with conventional 2D monolayers. Using a genetic screening platform, we identify MAPK14 (which encodes the protein kinase p38α) as a specific requirement for HGEC in spheroid culture. MAPK14/p38α has broad roles in programming the phosphoproteome, transcriptome, and metabolome of HGEC spheroids, yet has negligible impact on monolayer cultures. MAPK14 promotes tumorigenicity in vivo and is specifically required to sustain a sub-population of spheroid cells that is enriched in cancer stemness markers. Therefore, spheroid growth of HGEC activates unique biological programs, including p38α signaling, that cannot be captured using 2D culture models and are highly relevant to malignant disease pathology.

摘要

高级别子宫内膜癌(HGEC)转移生长和存活的分子基础仍知之甚少。在此,我们表明,3D球体培养中的腹水来源和原发性肿瘤HGEC细胞系忠实地再现了恶性腹腔积液的关键特征,并且与传统的2D单层细胞相比,呈现出根本不同的转录组、蛋白质组和代谢组图谱。使用基因筛选平台,我们确定MAPK14(编码蛋白激酶p38α)是球体培养中HGEC的特定需求。MAPK14/p38α在编程HGEC球体的磷酸蛋白质组、转录组和代谢组方面具有广泛作用,但对单层培养的影响可忽略不计。MAPK14在体内促进肿瘤发生,并且是维持富含癌症干性标志物的球体细胞亚群所特别需要的。因此,HGEC的球体生长激活了独特的生物学程序,包括p38α信号传导,这些程序无法使用2D培养模型捕获,并且与恶性疾病病理学高度相关。

相似文献

1
MAPK14/p38α shapes the molecular landscape of endometrial cancer and promotes tumorigenic characteristics.丝裂原活化蛋白激酶14/p38α塑造子宫内膜癌的分子格局并促进致瘤特性。
Cell Rep. 2025 Jan 28;44(1):115104. doi: 10.1016/j.celrep.2024.115104. Epub 2024 Dec 20.
2
/p38α Shapes the Molecular Landscape of Endometrial Cancer and promotes Tumorigenic Characteristics./p38α塑造子宫内膜癌的分子图景并促进致瘤特性。
bioRxiv. 2024 Jun 29:2024.06.25.600674. doi: 10.1101/2024.06.25.600674.
3
M2 macrophage-secreted KYNU promotes stemness remodeling and malignant behavior in endometrial cancer via the SOD2-mtROS-ERO1α-UPR axis.M2巨噬细胞分泌的犬尿氨酸酶通过SOD2-线粒体活性氧-内质网氧化还原酶1α-未折叠蛋白反应轴促进子宫内膜癌的干性重塑和恶性行为。
J Exp Clin Cancer Res. 2025 Jul 4;44(1):193. doi: 10.1186/s13046-025-03285-y.
4
In-depth evaluation of XPR1 as a new prognostic indicator for endometrial cancer.对XPR1作为子宫内膜癌新预后指标的深入评估。
BMC Cancer. 2025 Sep 2;25(1):1411. doi: 10.1186/s12885-025-14818-1.
5
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer.俄克拉荷马硝酮-007是一种靶向子宫内膜癌炎症和免疫代谢途径的有效抗癌治疗药物。
J Pharmacol Exp Ther. 2025 Jan;392(1):100004. doi: 10.1124/jpet.124.002223. Epub 2024 Nov 22.
6
Is There Any Difference in Stem Cell Population between Type I and Type II Endometrial Cancer? A Pilot Study.I型和II型子宫内膜癌的干细胞群有差异吗?一项初步研究。
J Mother Child. 2025 May 24;29(1):10-19. doi: 10.34763/jmotherandchild.20252901.d-24-00041. eCollection 2025 Feb 1.
7
Gas-Phase Fractionation Data-Independent Acquisition Analysis of 3D Cocultured Spheroid Tumor Model Reveals Altered Translational Processes and Signaling Using Proteomics.基于气相分离的三维共培养球体肿瘤模型的无数据依赖采集分析显示蛋白质组学改变了翻译过程和信号转导。
J Proteome Res. 2024 Aug 2;23(8):3188-3199. doi: 10.1021/acs.jproteome.3c00786. Epub 2024 Feb 27.
8
TREM1 is essential for maintaining stemness of liver cancer stem-like cells in hepatocellular carcinoma.触发受体表达于髓系细胞-1(TREM1)对于维持肝细胞癌中肝癌干细胞样细胞的干性至关重要。
Front Immunol. 2025 Jul 3;16:1618342. doi: 10.3389/fimmu.2025.1618342. eCollection 2025.
9
Unveiling the molecular mechanisms of human platelet lysate in enhancing endometrial receptivity.揭示人血小板裂解物增强子宫内膜容受性的分子机制。
Hum Reprod. 2025 Jul 15. doi: 10.1093/humrep/deaf118.
10
A bioprinted breast cancer model using bioinks of decellularized breast tissue for studying cancer stemness, invasion, and drug efficacy.一种使用脱细胞乳腺组织生物墨水的生物打印乳腺癌模型,用于研究癌症干性、侵袭和药物疗效。
Acta Biomater. 2025 Jul 26. doi: 10.1016/j.actbio.2025.07.054.

引用本文的文献

1
Longitudinal Proteomic Changes in HCT 116 Colon Cancer Spheroids During Growth.HCT 116结肠癌细胞球生长过程中的纵向蛋白质组学变化
J Proteome Res. 2025 Aug 1;24(8):4181-4190. doi: 10.1021/acs.jproteome.5c00207. Epub 2025 Jul 7.
2
Untargeted Metabolomics Reveals Acylcarnitines as Major Metabolic Targets of Resveratrol in Breast Cancer Cells.非靶向代谢组学揭示酰基肉碱是白藜芦醇在乳腺癌细胞中的主要代谢靶点。
Metabolites. 2025 Apr 5;15(4):250. doi: 10.3390/metabo15040250.
3
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.
TRIP13保护胰腺癌细胞免受内在的和治疗诱导的DNA复制应激。
NAR Cancer. 2025 Mar 20;7(1):zcaf009. doi: 10.1093/narcan/zcaf009. eCollection 2025 Mar.
4
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.TRIP13保护胰腺癌细胞免受内在及治疗诱导的DNA复制应激。
bioRxiv. 2025 Jan 27:2025.01.26.634889. doi: 10.1101/2025.01.26.634889.
5
Three-dimensional models: from cell culture to Patient-Derived Organoid and its application to future liposarcoma research.三维模型:从细胞培养到患者来源的类器官及其在未来脂肪肉瘤研究中的应用。
Oncol Res. 2024 Dec 20;33(1):1-13. doi: 10.32604/or.2024.053635. eCollection 2025.